CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 99 filers reported holding CUE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 9.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $220,984 | -37.0% | 96,080 | 0.0% | 0.00% | – |
Q2 2023 | $350,692 | +276.6% | 96,080 | +268.3% | 0.00% | – |
Q1 2023 | $93,120 | +158.3% | 26,084 | +106.2% | 0.00% | – |
Q4 2022 | $36,058 | +24.3% | 12,652 | 0.0% | 0.00% | – |
Q3 2022 | $29,000 | -9.4% | 12,652 | 0.0% | 0.00% | – |
Q2 2022 | $32,000 | -91.9% | 12,652 | -84.4% | 0.00% | – |
Q1 2022 | $396,000 | -56.8% | 81,050 | 0.0% | 0.00% | – |
Q4 2021 | $917,000 | -19.6% | 81,050 | +3.6% | 0.00% | – |
Q3 2021 | $1,140,000 | -51.0% | 78,230 | -60.8% | 0.00% | -100.0% |
Q2 2021 | $2,325,000 | -1.1% | 199,560 | +3.6% | 0.00% | 0.0% |
Q1 2021 | $2,351,000 | +1.9% | 192,667 | +4.5% | 0.00% | 0.0% |
Q4 2020 | $2,308,000 | -19.6% | 184,421 | -3.2% | 0.00% | 0.0% |
Q3 2020 | $2,869,000 | +32.0% | 190,615 | +115.0% | 0.00% | 0.0% |
Q2 2020 | $2,174,000 | +204.1% | 88,659 | +76.0% | 0.00% | – |
Q1 2020 | $715,000 | -10.3% | 50,387 | +0.4% | 0.00% | – |
Q4 2019 | $797,000 | +93.9% | 50,192 | +3.2% | 0.00% | – |
Q3 2019 | $411,000 | -0.2% | 48,646 | +6.2% | 0.00% | – |
Q2 2019 | $412,000 | +16.1% | 45,809 | 0.0% | 0.00% | – |
Q1 2019 | $355,000 | +127.6% | 45,809 | +38.4% | 0.00% | – |
Q4 2018 | $156,000 | -48.0% | 33,100 | 0.0% | 0.00% | – |
Q3 2018 | $300,000 | -23.7% | 33,100 | 0.0% | 0.00% | – |
Q2 2018 | $393,000 | +70.9% | 33,100 | +103.1% | 0.00% | – |
Q1 2018 | $230,000 | – | 16,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Corriente Advisors, LLC | 1,915,219 | $23,959,000 | 5.70% |
Prosight Management, LP | 906,569 | $11,341,000 | 5.24% |
P.A.W. CAPITAL CORP | 140,000 | $1,751,000 | 1.54% |
Voss Capital, LLC | 220,714 | $2,761,000 | 1.39% |
Robertson Stephens Wealth Management, LLC | 484,000 | $6,054,000 | 1.26% |
Slate Path Capital LP | 1,483,619 | $18,560,000 | 1.00% |
Nantahala Capital Management | 2,506,772 | $31,360,000 | 0.97% |
PRECEPT MANAGEMENT LLC | 150,000 | $1,877,000 | 0.76% |
SANDERS MORRIS HARRIS LLC | 193,591 | $2,449,000 | 0.56% |
Rock Creek Group, LP | 100,014 | $1,251,000 | 0.51% |